Multiplexed Proximity Ligation Assays to Profile Putative Plasma Biomarkers Relevant to Pancreatic and Ovarian Cancer
Open Access
- 1 March 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 54 (3), 582-589
- https://doi.org/10.1373/clinchem.2007.093195
Abstract
Background: Sensitive methods are needed for biomarker discovery and validation. We tested one promising technology, multiplex proximity ligation assay (PLA), in a pilot study profiling plasma biomarkers in pancreatic and ovarian cancer.Methods: We used 4 panels of 6- and 7-plex PLAs to detect biomarkers, with each assay consuming 1 μL plasma and using either matched monoclonal antibody pairs or single batches of polyclonal antibody. Protein analytes were converted to unique DNA amplicons by proximity ligation and subsequently detected by quantitative PCR. We profiled 18 pancreatic cancer cases and 19 controls and 19 ovarian cancer cases and 20 controls for the following proteins: a disintegrin and metalloprotease 8, CA-125, CA 19-9, carboxypeptidase A1, carcinoembryonic antigen, connective tissue growth factor, epidermal growth factor receptor, epithelial cell adhesion molecule, Her2, galectin-1, insulin-like growth factor 2, interleukin-1α, interleukin-7, mesothelin, macrophage migration inhibitory factor, osteopontin, secretory leukocyte peptidase inhibitor, tumor necrosis factor α, vascular endothelial growth factor, and chitinase 3–like 1. Probes for CA-125 were present in 3 of the multiplex panels. We measured plasma concentrations of the CA-125–mesothelin complex by use of a triple-specific PLA with 2 ligation events among 3 probes.Results: The assays displayed consistent measurements of CA-125 independent of which other markers were simultaneously detected and showed good correlation with Luminex data. In comparison to literature reports, we achieved expected results for other putative markers.Conclusion:Multiplex PLA using either matched monoclonal antibodies or single batches of polyclonal antibody should prove useful for identifying and validating sets of putative disease biomarkers and finding multimarker panels.Keywords
This publication has 27 references indexed in Scilit:
- Multiplexed protein detection by proximity ligation for cancer biomarker validationNature Methods, 2007
- Amplification of Tumor Hypoxic Responses by Macrophage Migration Inhibitory Factor–Dependent Hypoxia-Inducible Factor StabilizationCancer Research, 2007
- Direct observation of individual endogenous protein complexes in situ by proximity ligationNature Methods, 2006
- Bead-Based ELISA for Validation of Ovarian Cancer Early Detection MarkersClinical Cancer Research, 2006
- Usefulness of Plasma Vascular Endothelial Growth Factor in the Diagnosis of Pancreatic CarcinomaPancreas, 2005
- Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinomaGynecologic Oncology, 2004
- Protein detection using proximity-dependent DNA ligation assaysNature Biotechnology, 2002
- Utility of c-crbB-2 Expression in Tissue and Sera of Ovarian Cancer PatientsCancer Investigation, 2000
- CorrespondenceEuropean Journal Of Cancer, 1998
- Elevated Serum c-erbB-2 Protein Levels in Patients with Pancreatic Cancer: Correlation to Metastasis and Shorter SurvivalOncology, 1995